Rational design, synthesis, and verification of affinity ligands to a protein surface cleft
暂无分享,去创建一个
D. Choudhury | A. Axén | E. Carredano | H. Baumann | U. Tedebark | Y. Shinohara | S. Öhrman | O. Ersoy | Oguz Ersoy
[1] A. Ortiz,et al. Evaluation of docking functions for protein-ligand docking. , 2001, Journal of medicinal chemistry.
[2] C. Lowe,et al. New strategy for the design of ligands for the purification of pharmaceutical proteins by affinity chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[3] Bernd Meyer,et al. Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.
[4] C. Lowe,et al. Design, synthesis, and application of a Protein A mimetic , 1998, Nature Biotechnology.
[5] S. Spinelli,et al. Structure of a pancreatic α‐amylase bound to a substrate analogue at 2.03 Å resolution , 1997, Protein science : a publication of the Protein Society.
[6] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[7] R. Huber,et al. Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics. , 1996, Journal of molecular biology.
[8] T. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[9] B. Henrissat,et al. Structures and mechanisms of glycosyl hydrolases. , 1995, Structure.
[10] J. Peng,et al. Nuclear magnetic resonance-based approaches for lead generation in drug discovery. , 2001, Methods in enzymology.
[11] M. Wilchek,et al. An overview of affinity chromatography. , 2000, Methods in molecular biology.
[12] J. S. Dixon. Evaluation of the CASP2 docking section , 1997, Proteins.
[13] G. Speijers,et al. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use. , 1986, Developments in biological standardization.
[14] C. R. Lowe. Protein purification: Principles and practice , 1984 .